DDX55 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 1.236170E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.560300E-02 |
Normal-vs-Stage2 |
1.116420E-01 |
Normal-vs-Stage3 |
9.411100E-04 |
Normal-vs-Stage4 |
2.245700E-02 |
Stage1-vs-Stage2 |
9.061200E-01 |
Stage1-vs-Stage3 |
3.766000E-02 |
Stage1-vs-Stage4 |
4.127800E-01 |
Stage2-vs-Stage3 |
1.967030E-01 |
Stage2-vs-Stage4 |
5.922000E-01 |
Stage3-vs-Stage4 |
4.798800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.286200E-02 |
Normal-vs-AfricanAmerican |
3.796000E-03 |
Normal-vs-Asian |
6.387600E-01 |
Caucasian-vs-AfricanAmerican |
2.546200E-01 |
Caucasian-vs-Asian |
4.282000E-03 |
AfricanAmerican-vs-Asian |
3.260000E-03 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.101660E-02 |
Normal-vs-Female |
1.896300E-02 |
Male-vs-Female |
7.623200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.464200E-02 |
Normal-vs-Age(41-60Yrs) |
1.421510E-02 |
Normal-vs-Age(61-80Yrs) |
2.344200E-02 |
Normal-vs-Age(81-100Yrs) |
5.8986999995625E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.571200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.359400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.9807999999979E-05 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.246200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.443700E-04 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.382100E-04 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
8.799700E-04 |
Classical-VS-Follicular |
8.742400E-01 |
Classical-VS-Other |
7.524200E-01 |
Classical-VS-Normal |
3.140400E-02 |
Tall-VS-Follicular |
7.837900E-03 |
Tall-VS-Other |
2.167400E-01 |
Tall-VS-Normal |
8.2516000000088E-05 |
Follicular-VS-Other |
7.850600E-01 |
Follicular-VS-Normal |
1.392970E-01 |
Other-VS-Normal |
2.483000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.672000E-02 |
Normal-vs-N1 |
7.849800E-02 |
N0-vs-N1 |
8.942200E-01 |
|
|